Premium
New immunoglobulin brand for Guillain–Barré syndrome
Author(s) -
Koga Michiaki
Publication year - 2017
Publication title -
clinical and experimental neuroimmunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.297
H-Index - 15
ISSN - 1759-1961
DOI - 10.1111/cen3.12409
Subject(s) - guillain barre syndrome , open label , medicine , antibody , immunoglobulin g , immunology , clinical trial
Abstract Nomura et al. showed the efficacy and safety of freeze‐dried polyethylene glycol‐treated human immunoglobulin in a multicenter, open‐label and single‐arm trial for treatment of Guillain–Barré syndrome. Based on the results, a new source of immunoglobulin is indicated for Guillain–Barré syndrome in Japan.